脓毒症代谢组学特征随免疫活化状态变化
该研究为PROVIDE前瞻性临床研究的亚组分析,纳入希腊14个临床中心的210例符合Sepsis-3定义、伴肺部感染、急性胆管炎或原发性菌血症的脓毒症患者,比较三种免疫活化状态(MALS、免疫麻痹、未分类)的血浆代谢组学特征。非靶向代谢组学分析共检测1394种产物,差异丰度分析发现221种代谢物在不同免疫状态间显著不同。MALS与免疫麻痹及未分类患者相比,代谢物富集于泛醌生物合成、酪氨酸代谢和色氨酸代谢通路;MALS与未分类比较发现312种显著不同代谢物,而免疫麻痹与未分类比较仅发现2种差异代谢物。结果提示脓毒症不同免疫功能障碍伴随不同的代谢失调模式,MALS的代谢失调最强。
要点
- 在210例脓毒症患者中,MALS、免疫麻痹与未分类三种免疫状态间共221种代谢物存在显著差异。
- MALS与免疫麻痹及未分类患者相比,代谢物富集于泛醌生物合成、酪氨酸代谢和色氨酸代谢通路。
- MALS与未分类患者比较发现312种显著不同的代谢物,通路分析提示多个通路富集。
- 免疫麻痹与未分类患者比较仅发现2种差异调节代谢物。
- 结果提示MALS与最强的代谢失调相关,不同免疫功能障碍对应不同的代谢失调模式。
适用人群与场景
- 来自希腊14个临床中心的210例符合Sepsis-3定义的脓毒症患者,伴肺部感染、急性胆管炎或原发性菌血症。
诊断标准与关键阈值
- 免疫活化状态分类:巨噬细胞活化样综合征(MALS)以过度炎症为特征;脓毒症诱导的免疫麻痹;未分类或中间型患者,无严重免疫失调。
研究设计与关键结果
- 研究类型:PROVIDE前瞻性临床研究的亚组分析;样本量210例;14个临床中心;人群为符合Sepsis-3定义伴肺部感染、急性胆管炎或原发性菌血症的脓毒症患者;比较三种免疫活化状态(MALS、免疫麻痹、未分类)的血浆非靶向代谢组学特征,共检测1394种产物,未进行干预。
- 差异丰度分析共鉴定出221种在不同免疫状态间显著不同的代谢物。
- MALS与免疫麻痹及未分类患者比较,代谢物富集于泛醌生物合成、酪氨酸代谢和色氨酸代谢通路。
- MALS与未分类患者比较发现312种显著不同的代谢物,通路分析提示多个通路富集。
- 免疫麻痹与未分类患者比较仅发现2种差异调节代谢物。
证据类型、等级与局限
- 证据类型:前瞻性临床研究的亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the metabolomic profiles associated with different immune activation states in sepsis patients.
DESIGN: Subgroup analysis of the PROVIDE (a Personalized Randomized trial of Validation and restoration of Immune Dysfunction in severe infections and Sepsis) prospective clinical study.
SETTING: Results of the PROVIDE study showed that patients with sepsis may be classified into three states of immune activation: 1) macrophage-activation-like syndrome (MALS) characterized by hyperinflammation, sepsis-induced immunoparalysis, and 3) unclassified or intermediate patients without severe immune dysregulation.
PATIENTS OR SUBJECTS: Two hundred ten patients from 14 clinical sites in Greece meeting the Sepsis-3 definitions with lung infection, acute cholangitis, or primary bacteremia.
INTERVENTIONS: During our comparison, we did not perform any intervention.
MEASUREMENTS AND MAIN RESULTS: Untargeted metabolomics analysis was performed on plasma samples from 210 patients (a total of 1394 products). Differential abundance analysis identified 221 significantly different metabolites across the immune states. Metabolites were enriched in pathways related to ubiquinone biosynthesis, tyrosine metabolism, and tryptophan metabolism when comparing MALS to immunoparalysis and unclassified patients. When comparing MALS to unclassified, 312 significantly different metabolites were found, and pathway analysis indicated enrichment in multiple pathways. Comparing immunoparalysis to unclassified patients revealed only two differentially regulated metabolites.
CONCLUSIONS: Findings suggest distinct metabolic dysregulation patterns associated with different immune dysfunctions in sepsis: the strongest metabolic dysregulation is associated with MALS.
参考来源
- Kranidioti E, Ricaño-Ponce I, Antonakos N, et al. Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation. Crit Care Med. 2024. PMID: 39418210. doi:10.1097/CCM.0000000000006391
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。